MTIP
MTIP is a Swiss-based growth investor that specializes in scaling up healthtech companies in rapidly expanding global markets.
25/01/2021
How to invest responsibly? ▶️ 🌳🙋🏽📟 We have been doing this since 2017. Do you want to know more about our investment approach? Visit our website to learn more!
Our social responsibility | MTIP As long-term investors in healthtech innovation, we understand that value creation and social responsibility go hand-in-hand: both are critical to creating successful and sustainable businesses that improve lives.
13/01/2021
How did our portfolio company Oviva Schweiz became the leading behaviour-change company in Europe? 📰 Read the interview on Research2Guidance with their CEO Kai Eberhardt to find the answer to this question! 🔍
How Oviva became the leading behaviour-change company in Europe - Interview with Dr. sc. Kai Eberhardt, Co-Founder & CEO, Oviva - research2guidance Covid-19 has shed light on the growing importance of remote app diet coach driven behaviour-change programs in digital chronic care.
06/01/2021
Our Portfolio Company Quanta Dialysis Technologies is participating tomorrow in the Annual LifeSci Partners Corporate Access event!
Follow the link and register here for the panel "Disruptive Stories in MedTech"!
10th Annual LifeSci Partners Corporate Access Event - Jan 6th to 14th, 2021 The information on this site is not intended to be, nor shall constitute, an offer to sell nor solicitation or any offer to buy any security. The information presented on this site is subject to change without notice, and LifeSci Advisors assumes no responsibility to update this information. LifeSci...
05/01/2021
New year, new start! We empower innovation that improves lives! 👦🏾👱🏽♀️👨🏿 Are you interested in what we do? We are a Swiss-based growth investor that specializes in scaling up companies in rapidly expanding .
💻 Find out more about MTIP AG on our website! www.mtip.ch
MTIP - Healthtech Investors Empowering innovation that improves lives Home Welcome to MTIP MTIP is a Swiss-based growth investor that specializes in scaling up healthtech companies in rapidly expanding global markets. We invest in digitally-connected, decentralized and patient-centric medical technology leaders, based primaril...
08/12/2020
Knowledge. 📚 Experience. 🔎 Passion. 💪
At MTIP, our dedicated professionals share a commitment to excellence, a passion for problem-solving, and faith in the value of collaboration, cooperation and mutual trust.
➡️ Visit our teampage: www.mtip.ch/en/team
Our team | MTIP At MTIP, our dedicated professionals share a commitment to excellence, a passion for problem-solving, and a faith in the value of collaboration, cooperation and mutual trust.
Cynerio, our industry-leading Healthcare IoT cybersecurity company, launched a Threat Intelligence Depository, with the latest news and real-time updates on newly discovered vulnerabilities and threats in medical and IoT devices. ▶️ Learn more👾
https://www.cynerio.com/healthcare-iot-threat-intelligence
19/10/2020
We believe that honest, straightforward and mutually beneficial relationships with investors, entrepreneurs and other stakeholders are critical to long-term success. 🏆
🔎 Learn more about our company: www.mtip.ch/about-us
About us | MTIP MTIP is a pan-European Healthtech growth investor, based in Basel Switzerland. We invest in digitally-connected, decentralized and patient-centric medical technology leaders, with offerings that provide clear health-related economic benefits. Our entrepreneurial investment team, which has complement...
23/09/2020
➡️ Do you want to get insights about MTIP, our investment approach and about our Portfolio Companies?
Sign up for our Newsletter! ✏️
10/09/2020
👩💻👨💻 Tune in for this complementary 40-minute session featuring leading healthtech investors from across Europe who will outline the impact of COVID-19, opportunities across the ecosystem and how investors are supporting and accelerating Europe's healthtech innovation. David Germonpré will represent MTIP in this session!
➡️ September 15th at 9:10 CEST ⬅️
Europe’s Next Wave | Healthtech Leaders LSX’s Healthtech Leaders: Virtual Partnering & Investment is a c-level, online showcase and partnering experience designed to provide a platform for Healthtech companies to engage international investors and strategic partners.
Trialbee Partners with Clinerion for Expanded Access to Global Real-World Data to Accelerate Patient Recruitment for Clinical Trials
This month Trialbee announced their new partnership with Clinerion Ltd. The Companies will focus on working together to accelerate time to market by shortening and enrollment timelines as well as reducing costs associated with patient recruitment and loss-to-follow-up. Congratulations on the new collaboration 👏
trialbee.com Trialbee is pleased to announce our partnership with Clinerion to accelerate time to market by shortening patient recruitment and enrollment timelines and reduce costs associated with patient recruitment and loss-to-follow-up.
Lumeon Raises $30M in Funding to Support U.S. Growth - Lumeon
Our Portfolio Company Lumeon has secured $30 million in funding!
The new investment will support their groth in the US market and help them develop and scale new systems of delivery.
➡️ Read more in their press release.
lumeon.com Lumeon, the leader in care pathway orchestration, today announced that it has closed $30M in Series D funding, led by new investors Optum Ventures
Chronic diseases are the biggest health problem in our society (Part I)
We've started publishing on Medium 📰!
👓 Read our first story: «Chronic diseases are the biggest health problem in our society (Part I)» 👩⚕️
medium.com By definition, chronic disease is one lasting 32 months or more. And also: Chronic diseases generally cannot be prevented by vaccines or…
Webinar: COVID-Proof Deep Tech startups
7 days to go! Don't miss the Silicon Roundabout's Webinar on the 29th of July. Elizabeth Law will talk about the state of the Eurpean VC landscape! 📺
eventbrite.co.uk COVID-proof Deep Tech startups exist! Connect with DeepTech startups whose businesses have remained resilient to COVID conditions.
Tech Tour
🎤 How is the crisis impacting the funding landscape for startups? Our CEO Christoph Kausch answers this and more questions in Tech Tour's Interview!📰
🔎 Read his response here: https://techtour.com/news/2020/4-health-vcs.html
techtour.com 29 May 2020 4 Health VCs Share Their Business Priorities and What is Next Venture Capital financing in Q1’20 will be the second steepest decline in the past 10 years according to data from CB Insights. We asked 3 investors from our network to share their business priorities, how they adjusted thei...
Webinar: COVID-Proof Deep Tech startups
Our Head of Investor Relations, Elizabeth Law, is participating in Silicon Roundabout's Webinar 💻 "COVID-Proof Deep Tech startups". She will introduce you to the state of the European VC landscape!
🕜 The Webinar is on the 29th of July at 13:30-14:30 (CEST). ➡️ Register here
eventbrite.co.uk COVID-proof Deep Tech startups exist! Connect with DeepTech startups whose businesses have remained resilient to COVID conditions.
Galileo - G-testet: Kann dieses Gerät den Arztbesuch ersetzen?
Tyto Care's TytoHome wurde bei Galileo getestet! 👩⚕️
Wie unsere Portfolio Firma abschneidet?
➡️ Sehen Sie es sich selbst im Video an!
prosieben.ch Mit einem neuen Gerät soll man die eigene Körpertemperatur, den Herzschlag und die Lungenfunktion und noch vieles mehr messen und einen Arzt online hinzuschalten können. Doch kann dieses Gadget wirklich den Arztbesuch ersetzen? "Galileo" macht den Test.
Cynerio Named a Leader in Connected Medical Device Security Evaluation by Independent Research Firm
We are delighted to share the news with you that our Portfolio Company Cynerio, the outstanding provider of Internet of Medical Things (IoMT) security solutions 💻👾, was awarded as "Leader" 🏆 in the “The Forrester New Wave™: Connected Medical Device Security, Q2 2020” report by Forrester Research.
cynerio.com Cynerio today announced that they were named a leader and received among the highest scores in the current offering and strategy categories in “The Forrester New Wave™: Connected Medical Device Security, Q2 2020,”
Europe’s Next Wave | Healthtech Leaders
Help build Europe’s next wave! 🏄♀️
Join leading European healthtech investors who will outline the impact of , opportunities across the ecosystem, and how investors are supporting and accelerating Europe's healthtech innovation! 🚀
And we are participating! Our Investor Partner David Germonpré is one of the speakers on Tuesday September 15th 09h10 BST / 10h10 CEST! 📢
➡️ Klick on the Pic and sign up now! 🖊
lsxleaders.com LSX’s Healthtech Leaders: Virtual Partnering & Investment is a c-level, online showcase and partnering experience designed to provide a platform for Healthtech companies to engage international investors and strategic partners.
Empowering Innovation that improves lives.
MTIP is a pan-European Healthtech growth investor, based in Basel Switzerland. We invest in digitally-connected, decentralized and patient-centric medical technology leaders, with offerings that provide clear health-related economic benefits. Our entrepreneurial investment team, which has complementary private equity skills and exceptional deal-making capabilities, actively works with our portfolio companies to boost growth. MTIP efficiently deploys capital to unlock value and generate attractive returns for our investors.